• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化患者的糖尿病药物治疗。

Pharmacotherapy of diabetes in cystic fibrosis patients.

机构信息

The Ohio State University, Nationwide Children's Hospital, 700 Children's Dr W307, Columbus, OH 4320, USA.

出版信息

Expert Opin Pharmacother. 2010 Apr;11(5):771-8. doi: 10.1517/14656561003592151.

DOI:10.1517/14656561003592151
PMID:20166842
Abstract

IMPORTANCE OF THE FIELD

Cystic fibrosis-related diabetes (CFRD) is a unique type of diabetes. In this article I review the pathophysiology of CFRD to gain insight as to why these patients have clinical features of both type 1 and 2 diabetes (DM). The reader will also learn that, although CFRD is different from type 1 and 2 DM, the development of diabetes-induced complications is similar to other types of DM. These complications can include retinopathy, nephropathy and neuropathy resulting from uncontrolled hyperglycemia; however, hyperglycemia and/or insulin deficiency in people with CFRD may exacerbate underlying CF problems, such as decreased pulmonary function and weight loss.

AREAS COVERED IN THIS REVIEW

Review medical therapy of CFRD including the over-riding goal of maintaining blood glucose levels in a range as close to normal as possible. The other important goal for diabetes management is to prevent diabetes complications and to encourage psychological wellbeing of the patient. However, as reviewed in this article, the underlying medical condition of people with CF and the basic metabolic differences caused by the disease often provide challenges in maintaining optimal diabetes control.

WHAT THE READER WILL GAIN

The reader will gain an understanding of how CFRD physically affects the patient with CF and the various pharmacologic therapies available for treatment of this type of diabetes. Furthermore they will gain insight into areas where more research is needed.

TAKE HOME MESSAGE

Cystic fibrosis-related diabetes is unique to CF and thus deserves disease specific medical therapy.

摘要

重要性领域

囊性纤维化相关性糖尿病(CFRD)是一种独特的糖尿病类型。在本文中,我回顾了 CFRD 的病理生理学,以深入了解为什么这些患者具有 1 型和 2 型糖尿病(DM)的临床特征。读者还将了解到,尽管 CFRD 与 1 型和 2 型 DM 不同,但糖尿病引起的并发症的发展与其他类型的 DM 相似。这些并发症包括由高血糖引起的视网膜病变、肾病和神经病变;然而,CFRD 患者的高血糖和/或胰岛素缺乏可能会加重潜在的 CF 问题,如肺功能下降和体重减轻。

涵盖的领域

本综述包括 CFRD 的医学治疗,包括将血糖水平控制在尽可能接近正常范围内的首要目标。糖尿病管理的另一个重要目标是预防糖尿病并发症并鼓励患者的心理健康。然而,如本文所述,CF 患者的潜在医疗状况和由该疾病引起的基本代谢差异常常在维持最佳糖尿病控制方面带来挑战。

读者将获得

读者将了解 CFRD 如何对 CF 患者造成身体影响,以及治疗这种类型糖尿病的各种药物治疗。此外,他们将深入了解需要进一步研究的领域。

带回家的信息

囊性纤维化相关性糖尿病是 CF 所特有的,因此值得采用针对疾病的特定医学治疗。

相似文献

1
Pharmacotherapy of diabetes in cystic fibrosis patients.囊性纤维化患者的糖尿病药物治疗。
Expert Opin Pharmacother. 2010 Apr;11(5):771-8. doi: 10.1517/14656561003592151.
2
Pharmacological management of cystic fibrosis related diabetes.囊性纤维化相关糖尿病的药物治疗
Expert Rev Clin Pharmacol. 2018 Feb;11(2):185-191. doi: 10.1080/17512433.2018.1421065. Epub 2018 Jan 5.
3
The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.囊性纤维化患儿葡萄糖不耐受的病程:一项回顾性研究——初步报告
Dev Period Med. 2015 Jan-Mar;19(1):80-91.
4
Microvascular complications in cystic fibrosis-related diabetes.囊性纤维化相关糖尿病的微血管并发症
Diabetes Care. 2007 May;30(5):1056-61. doi: 10.2337/dc06-1576. Epub 2007 Feb 23.
5
Glucose intolerance in cystic fibrosis patients.囊性纤维化患者的葡萄糖不耐受
Paediatr Respir Rev. 2001 Sep;2(3):253-9. doi: 10.1053/prrv.2001.0148.
6
A review of the management of two common clinical problems found in patients with cystic fibrosis: cystic fibrosis-related diabetes and poor growth.对囊性纤维化患者中发现的两个常见临床问题的管理综述:囊性纤维化相关糖尿病和生长发育不良。
Horm Res. 2007;68 Suppl 5:113-6. doi: 10.1159/000110603. Epub 2007 Dec 10.
7
Clinical importance of cystic fibrosis-related diabetes.囊性纤维化相关糖尿病的临床重要性。
J Cyst Fibros. 2004 Dec;3(4):209-22. doi: 10.1016/j.jcf.2004.08.001. Epub 2004 Oct 27.
8
Advances in the detection and management of cystic fibrosis related diabetes.囊性纤维化相关糖尿病的检测与管理进展
Curr Opin Pediatr. 2015 Aug;27(4):525-33. doi: 10.1097/MOP.0000000000000251.
9
Diabetic keto-acidosis as a presentation of cystic fibrosis-related diabetes: a case report.糖尿病酮症酸中毒为囊性纤维化相关性糖尿病的表现:病例报告。
J Diabetes Complications. 2011 Mar-Apr;25(2):137-41. doi: 10.1016/j.jdiacomp.2010.05.003. Epub 2010 Jul 24.
10
Managing diabetes in cystic fibrosis.囊性纤维化中的糖尿病管理。
Diabetes Obes Metab. 2010 Oct;12(10):858-64. doi: 10.1111/j.1463-1326.2010.01250.x.

引用本文的文献

1
Hemoglobin A and fructosamine correlate in a patient with sickle cell disease and diabetes on chronic transfusion therapy.血红蛋白 A 和果糖胺在接受慢性输血治疗的镰状细胞病合并糖尿病患者中相关。
Pediatr Blood Cancer. 2020 Sep;67(9):e28499. doi: 10.1002/pbc.28499. Epub 2020 Jul 3.
2
Ceramide in cystic fibrosis: a potential new target for therapeutic intervention.囊性纤维化中的神经酰胺:治疗干预的潜在新靶点。
J Lipids. 2011;2011:674968. doi: 10.1155/2011/674968. Epub 2010 Dec 28.